Top Markets
Coin of the day
SeqLL Inc. SeqLL Inc.

SeqLL Inc.

SQL
Classement en actions #17410
Globally, SeqLL Inc. operates as a life sciences enterprise, providing... Globally, SeqLL Inc. operates as a life sciences enterprise, providing specialized instrumentation and research services. The company's primary focus involves the innovation, refinement, and production of cutting-edge genetic analysis technologies. Among its key offerings is the proprietary true single molecule sequencing (tSMS) platform, which facilitates the direct sequencing of DNA and RNA at the individual molecular level. SeqLL has established collaborative agreements with a range of esteemed organizations, including Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. Its diverse clientele encompasses academic institutions, governmental agencies, hospitals and medical centers, pharmaceutical and biotechnology companies, and various non-profit research groups. Established in 2013, the company maintains its headquarters in Billerica, Massachusetts.
Prix de l'action
$6.60
Dernière synchronisation: 2025-02-06
Capitalisation boursière
$242.77M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange SeqLL Inc. (SQL)

Catégorie

Ratio P/S pour SeqLL Inc. (SQL)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de SeqLL Inc., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour SeqLL Inc. de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
4.95 -
US
5.98 -
US
- -
CN
17.03 -
US
2.53 -
US